EUVIMED · CrossrefJournal
Breast Cancer: Targets and Therapy
ISSN 1179-1314 · Informa UK Limited
Latest articles
BCAR4, BCAR3 and EGFR Display Different Degrees of Cross-Resistance to Endocrine Mono- and Combination Therapies in Hormone Receptor Positive, HER2 Negative Breast Cancer
The Cathepsin Network: Multifaceted Regulators and Emerging Therapeutic Targets in Breast Cancer
Stigmasterol Inhibits Breast Cancer Stemness and Tumor Growth by Suppressing TGF-β/SMAD Signaling Pathway
The Lactate Dehydrogenase-to-Albumin Ratio (LAR) for Estimating Survival in Surgically Treated Breast Cancer Patients Undergoing Subsequent Radiotherapy: A Single-Center Retrospective Cohort Study
Dual Primary Malignancies in Breast Cancer: Clinical Characteristics and Survival Predictors Among Hakka Women in Meizhou
Regulation and Tumor-Promoting Functions of PD-L1 in Breast Cancer: Mechanisms, Tumor Microenvironment, and Therapeutic Implications
FOXP3 Expression in T Cells and Neoplastic Cells: Prognostic Implications Within the Breast Cancer Tumor Microenvironment
KLK11 Overexpression Inhibits YAP-Associated Signaling and Suppresses Malignant Phenotypes in Triple-Negative Breast Cancer Cells
Rethinking Antioxidant Use in Breast Cancer: A Redox Decision-Node Framework for Therapeutic Risk and Translation
Two Niches, One Disease: Brain and Leptomeningeal Metastases in Breast Cancer: A Narrative Review
Early Postoperative NLR Change and Breast Cancer Recurrence: A Retrospective Day-30 Landmark Cohort Study
Adjuvant Trastuzumab Emtansine or Trastuzumab in Initially HER2-Positive Breast Cancer with Residual IHC 0–2+: A Retrospective Multicenter Cohort
MCV–Neutropenia Risk Score and Overall Survival in HR+/HER2− Advanced Breast Cancer: A Multicenter Retrospective Landmark Analysis
Long Non-Coding RNA PVT1 Promotes Doxorubicin Resistance by Inhibiting Ferroptosis in Breast Cancer
Lipid Metabolic Reprogramming in Breast Cancer: Mechanisms and Emerging Therapeutic Strategies
Integrative Network-Based Transcriptomic Analysis Identifies Niclosamide as a Candidate Repositioned Drug for Breast Cancer
Expression Profiling of SWI/SNF Complex Subunits in Triple-Negative Breast Cancer Using Tissue Microarray and Immunohistochemistry
Estrogen-Driven Breast Carcinogenesis in a Rat Model is Linked to Retroelement Activation and Inflammation and is Susceptible to Lamivudine Treatment
CYP4B1 Expression in Breast Cancer: An Immunohistochemical Study with Complementary in silico Analyses
AIM2 Lactylation Regulates Radiotherapy Sensitivity in Triple-Negative Breast Cancer
Application of Shear Wave Elastography Combined with Tumor Markers in the Differential Diagnosis of Benign and Malignant Breast Masses
Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling
miR-1911-3p Regulates Malignant Biological Behaviors and Glycolytic Activity of Triple-Negative Breast Cancer via FBLN5
HER2 Expression and Axillary Metastasis in Treatment-Naïve Early Breast Cancer
Prognostic Significance of Pretreatment Mean Platelet Volume in Patients with Recurrent or De Novo Metastatic Breast Cancer: A Single-Center Retrospective Study
Hemodynamic Inflow-Outflow Profiling as an Integrated DCE-MRI Biomarker for Diagnosis and Risk Stratification in Breast Cancer: A Multicenter Retrospective Study
Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer
Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
SLC2A9-Mediated Uric Acid Homeostasis Modulates Apoptosis in TNBC
EUVIMED